×
返回 Agenda
S34 : Pediatric Drug Development and Evidence Strategies in Japan in the Era of Global Clinical Trials
Session Chair(s)
Kazuhiro Kanmuri, PhD
Executive Officer, Head of Development Div., Tanabe Pharma Corporation, Japan
Speaker(s)
Satoshi Shoji, PhD
Manager, Pharmacometrician, Clinical Pharmacology, Pfizer R&D Japan G.K., Japan
Takashi Nagakubo, PhD
Advisor, Global Statistical Science Japan, Eli Lilly Japan K.K., Japan
Foteini Strimenopoulou, PhD
Principal Statistician, UCB Pharma, United Kingdom
Satrajit Roychoudhury, PhD
Executive Director, Statistical Research and Innovation, Pfizer, United States
Reiko Nakashima
Office of New Drug III, Pharmaceuticals and Medical Devices Agency (PMDA), Japan